Skip to main content

Diagnostic Imaging Market Size Worth USD 54.44 Billion in 2032 | Emergen Research

Factors such as growing prevalence of cancer and cardiac diseases and technological advancements are creating high demand for diagnostic imaging, thus is expected to drive Diagnostic Imaging Market revenue growth

Vancouver, Dec. 05, 2023 (GLOBE NEWSWIRE) — The global diagnostic imaging market is poised for robust growth, with a projected revenue Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period, according to the latest market research report. The market, valued at USD 29.00 Billion in 2022, is being propelled by factors such as the increasing prevalence of chronic diseases, technological advancements, and a growing demand for advanced diagnostic imaging.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @  https://www.emergenresearch.com/request-sample/2534

Key Market Drivers:

Rising Prevalence of Chronic Diseases:

The global burden of chronic diseases, especially among the aging population, is a significant driver of market growth. With over 80% of older individuals in the United States affected by at least one chronic ailment, the demand for diagnostic imaging, particularly in oncology, is on the rise.

Technological Advancements:

The integration of Artificial Intelligence (AI) and machine learning technologies into diagnostic imaging is revolutionizing the industry. Companies like Koninklijke Philips N.V. are leading the way with AI-powered diagnostic tools, improving workflow solutions and introducing intelligent diagnostic equipment, enhancing diagnostic speed and accuracy.

Market Challenges:

Cost Constraints:

The high cost of diagnostic imaging systems, coupled with the substantial capital investment required for installation, poses a challenge, particularly in developing countries. The financial constraints of healthcare facilities hinder the adoption of new systems, leading to increased demand for affordable alternatives.

Shortage of Trained Professionals:

A shortage of trained professionals in the healthcare sector is impeding market growth. The need for skilled individuals to operate diagnostic imaging equipment remains a limiting factor, affecting the effective utilization of advanced technologies.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2534

Trends and Innovations:

AI Integration in Radiology:

The integration of AI technologies into radiology is a growing trend, enhancing the precision and speed of radiographic interpretation. Philips, for instance, received FDA clearance for its AI-powered smart speed software, improving MRI efficiency threefold compared to traditional scanners.

Segment Insights:

Oncology Dominates: The oncology segment accounted for the largest revenue share in 2022, driven by the increasing incidence of cancer globally. Diagnostic imaging plays a crucial role in cancer care, aiding in the identification and staging of tumors.

Orthopedics on the Rise: The orthopedics segment is expected to experience the fastest revenue growth rate, attributed to advancements in diagnostic imaging technologies addressing joint injuries, degenerative bone issues, and fractures.

Ultrasound Leads in Product Type:

The ultrasound segment registered the fastest revenue growth rate in 2022 due to increased demand for advanced equipment. Innovations, such as portable ultrasound systems, are contributing to the segment’s growth.

End-Use Insights:

Diagnostic imaging centers are expected to register the fastest revenue growth rate, driven by the utilization of various imaging machines for planning and executing minimally invasive procedures.

Regional Insights:

North America Dominates:

North America accounted for the largest revenue share in 2022, driven by the rising number of imaging centers utilizing advanced technology. The region is expected to maintain its leadership position with approximately 18,861 imaging facilities in the United States by February 2023.

Asia Pacific Growth:

The Asia Pacific market is poised for significant revenue growth, fueled by the growing prevalence of chronic diseases. The region, with approximately 27.7 million Australians undergoing diagnostic imaging services, is expected to witness an upsurge in the occurrence of age-related conditions.

European Advancements:

The European market is expected to experience moderately fast revenue growth, attributed to the presence of well-established healthcare facilities and the launch of technologically advanced devices. The rise in chronic diseases is necessitating the use of improved diagnostic tools, driving market growth.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2534

Scope of Research

Report DetailsOutcome
Market size in 2022USD 29.0 Billion
CAGR (2023–2032)6.5%
Revenue forecast to 2032USD 54.44 Billion
Base year for estimation2022
Historical data2019-2021
Forecast period2023–2032
Quantitative unitsRevenue in USD Billion and CAGR in % from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredApplication, product type,  end-use, and region
Regional scopeNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scopeU.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA
Key companies profiledGE Healthcare, Koninklijke Philips N.V., Siemens Healthineers
Canon Diagnostic Systems Corporation, Mindray Diagnostic International, Esaote, Hologic, Inc., Samsung Medison Co., Ltd., Koning Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., Cubresa Inc., Johnson & Johnson Services, Inc., Narang Diagnostic Limited, ONRAD, Inc., Hitachi, Ltd., Carestream Health, Shimadzu Corporation, Akumin Inc., RamSoft, Inc.
Customization scope10 hours of free customization and expert consultation

Major Companies and Competitive Landscape

The global diagnostic imaging market is highly fragmented, with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective diagnostic imaging solutions. Some major players included in the global diagnostic imaging market report are:

  • GE Healthcare
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • Canon Diagnostic Systems Corporation
  • Mindray Diagnostic International
  • Esaote
  • Hologic, Inc.
  • Samsung Medison Co., Ltd.
  • Koning Corporation
  • PerkinElmer Inc.
  • FUJIFILM VisualSonics Inc.
  • Cubresa Inc.
  • Johnson & Johnson Services, Inc.
  • Narang Diagnostic Limited
  • ONRAD, Inc.
  • Hitachi, Ltd.
  • Carestream Health
  • Shimadzu Corporation
  • Akumin Inc.
  • RamSoft, Inc.

Strategic Development

  • In 2022, the Definium 656 HD represents GE Healthcare’s cutting-edge fixed X-ray system. As the most advanced version of the Overhead Tube Suspension (OTS) system in GE Healthcare’s range of fixed X-ray products, it ensures uniform, highly automated, and effective examinations. This technology instills clinical confidence, streamlines workflow, enhances uniformity, and minimizes errors, ultimately aiding in the efficient operation of radiology departments.
  • In 2022, Siemens Healthineers unveiled MAGNETOM Viato.Mobile, its latest MRI scanner designed for mobile applications, features a patient bore of 70 cm. The aim is to provide top-notch innovations at 1.5 Tesla for mobile use through MAGNETOM Viato.Mobile. Housed in a trailer setup for enhanced flexibility in MR imaging deployment, the scanner can be easily relocated or remain at the customer’s site for prolonged usage.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/diagnostic-imaging-market

For the purpose of this report, Emergen Research has segmented the global diagnostic imaging market on the basis of application, product type, end-use, and region:

  • Application Outlook (Revenue, USD Billion; 2019-2032)
    • Cardiology
    • Oncology
    • Neurology
    • Orthopedics
    • Gynecology
    • Others
  • Product Type Outlook (Revenue, USD Billion; 2019-2032)
    • X-ray Devices
      1. Digital X-Ray
        • Direct Radiography Systems
        • Computed Radiography Systems
      2. Analog X-Ray
      3. Stationary X-Ray
      4. Portable X-Ray
    • Magnetic Resonance Imaging (MRI)
      1. Closed MRI
      2. Open MRI
      3. High and Very High Field MRI
      4. Low-to-Mid-Field MRI
      5. Ultra-High-Field MRI
    • Ultrasound
      1. 2D Ultrasound
      2. 3D and 4D Ultrasound
      3. Doppler Ultrasound
      4. Contrast-Enhanced Ultrasound
      5. Trolley/Cart-Based Ultrasound
      6. Compact/Portable Ultrasound
      7. POC Ultrasound
    • CT scan
      1. Conventional CT Scan
        • High-Slice CT Scan
        • Mid-Slice CT Scan
        • Low-Slice CT Scan
      2. Cone Beam CT Scan
    • Nuclear Imaging
      1. PET System
        • Standalone PET Systems
        • Hybrid PET Systems
      2. SPECT Systems
        • Standalone SPECT Systems
        • Hybrid SPECT Systems
    • Mammography

     

  •  End-Use Outlook (Revenue, USD Billion; 2019-2032)
    • Hospitals
    • Diagnostic Imaging Centers
    • Others
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Immunotherapy Drugs Market By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines, and Others), By Disease (Cancer, Autoimmune Diseases, Infectious Diseases, and Others), and By Region Forecast To 2030

Healthcare Supply Chain Management Market By Component (Software, Hardware), By Delivery Mode (On-premises Delivery, Cloud-based Delivery), By End-user (Manufacturers, Providers, Distributors), and By Region Forecast to 2027

Drug Screening Market, By Products and Services (Drug Screening Products and Drug Screening Services), By Sample Type (Urine Samples, Hair Samples, Breath Samples, Oral Samples, and Others), By End-Use, and By Region Forecast to 2030

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region Forecast to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.